Clinical Trial

ELUDYN: Assessment of Intra-individual Variability of Vascular Dynamics of Gadopiclenol Injection Parameters in Contrast-enhanced MRI

Study acronym: ELUDYN
Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This study aims to understand how the volumes and speeds of intravenous injection of a recent type of contrast agent can be optimized in order to improve the information provided by medical images. To do this, five MRI scans lasting approximately 30 minutes will be performed on 10 healthy volunteers over a period of approximately 10 months. The images will then be analyzed by three radiologists who will view the images in different orders, without knowing which injection parameters were used. They will decide, based on their impressions but also on precise measurements in the images, which parameters produce the best images.
Protocol Amendment History 4 changes
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-04-30
notable Enrollment increased: 10 -> 14 participants 2026-04-30
notable Primary completion moved earlier: 2027-06-01 -> 2026-10-01 2026-04-30
minor Completion moved earlier: 2027-12-31 -> 2026-12-31 2026-04-30
Trial Details
NCT Number NCT07346131
Lead Sponsor Hôpital Fribourgeois
Conditions Contrast Agent, Medical Imaging Data, MRI Image Enhancement
Enrollment 14 participants
Start Date 2026-01-07
Primary Completion 2026-10-01 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-29